Cogent Biosciences, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC reported a significant reduction in their beneficial ownership of Cogent Biosciences, Inc. common stock following a conversion and block sale.
NASDAQ
SCHEDULE: Fairmount Funds Sells Cogent Bio Shares
Fairmount Funds Management LLC reported a block sale of 3.5 million shares of Cogent Biosciences, Inc. common stock at $36.40 per share, reducing its beneficial ownership to 9.9%.
NASDAQ
Fairmount Funds Management and Fairmount Healthcare Fund II GP LLC report a 9.9% beneficial ownership in Cogent Biosciences, Inc. and enter a 45-day lock-up agreement following recent company offerings.
NASDAQ
SCHEDULE: Fairmount Funds Management Increases Stake in Cogent Biosciences to 9.9% Following Public Offering
Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have increased their beneficial ownership in Cogent Biosciences, Inc. to 9.9% after purchasing 2,777,777 shares of common stock for approximately $25 million in a recent public offering.